Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)
Public ClinicalTrials.gov record NCT00444925. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
12-Week, Randomized, Double-Blind, Double-Dummy,Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Comparison To Tolterodine ER In Patients With Overactive Bladder (OAB)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy and safety of fesoterodine in comparison to tolterodine and placebo for overactive bladder
Study identification
- NCT ID
- NCT00444925
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,712 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2007 (Type not available)
- Primary completion
- Jul 2008 (Actual)
- Completion
- Jul 2008 (Actual)
- Last update posted
- Mar 24, 2015
2007 – 2008
United States locations
- U.S. sites
- 41
- U.S. states
- 27
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Homewood | Alabama | 35209 | — |
| Pfizer Investigational Site | Huntsville | Alabama | 35801 | — |
| Pfizer Investigational Site | Mobile | Alabama | 36608 | — |
| Pfizer Investigational Site | Carmichael | California | 95608 | — |
| Pfizer Investigational Site | Orangevale | California | 95662 | — |
| Pfizer Investigational Site | San Diego | California | 92103-6204 | — |
| Pfizer Investigational Site | Aurora | Colorado | 80012 | — |
| Pfizer Investigational Site | Waterbury | Connecticut | 06708 | — |
| Pfizer Investigational Site | Miami | Florida | 33186 | — |
| Pfizer Investigational Site | Wellington | Florida | 33414 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Coeur d'Alene | Idaho | 83814 | — |
| Pfizer Investigational Site | Sandpoint | Idaho | 83864 | — |
| Pfizer Investigational Site | Aurora | Illinois | 60504 | — |
| Pfizer Investigational Site | West Des Moines | Iowa | 50266 | — |
| Pfizer Investigational Site | Newton | Kansas | 67114 | — |
| Pfizer Investigational Site | Shrevport | Louisiana | 71106 | — |
| Pfizer Investigational Site | Watertown | Massachusetts | 02472 | — |
| Pfizer Investigational Site | Chaska | Minnesota | 55318 | — |
| Pfizer Investigational Site | Lawrenceville | New Jersey | 08648 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87109 | — |
| Pfizer Investigational Site | Garden City | New York | 11530 | — |
| Pfizer Investigational Site | Mineola | New York | 11501 | — |
| Pfizer Investigational Site | Burlington | North Carolina | 27215 | — |
| Pfizer Investigational Site | Concord | North Carolina | 28025 | — |
| Pfizer Investigational Site | Huntersville | North Carolina | 28078 | — |
| Pfizer Investigational Site | Dayton | Ohio | 45439 | — |
| Pfizer Investigational Site | Allentown | Pennsylvania | 18103 | — |
| Pfizer Investigational Site | Allentown | Pennsylvania | 18106 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15212 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15213-3180 | — |
| Pfizer Investigational Site | East Providence | Rhode Island | 02914 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29425 | — |
| Pfizer Investigational Site | Columbia | South Carolina | 29201 | — |
| Pfizer Investigational Site | Kingsport | Tennessee | 37660 | — |
| Pfizer Investigational Site | Milan | Tennessee | 38358 | — |
| Pfizer Investigational Site | Houston | Texas | 77024 | — |
| Pfizer Investigational Site | Provo | Utah | 84604 | — |
| Pfizer Investigational Site | Chesapeake | Virginia | 23320 | — |
| Pfizer Investigational Site | Seattle | Washington | 98104 | — |
| Pfizer Investigational Site | Menomonee Falls | Wisconsin | 53051 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 137 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00444925, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 24, 2015 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00444925 live on ClinicalTrials.gov.